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1. Introduction 
Diabetes mellitus is a chronic disorder in the metabolism of carbohydrates; proteins and fat due to absolute or 
relative deficiency of insulin secretion with / without vary in degree of insulin resistance. Diabetes mellitus is a metabolic 
disease which is found to be old as mankind and is seems to be high all over the world [1]. It is also a major cause of 
disability and hospitalization which results in significant financial burden [2]. 
  Salacia is a valuable genus comprising of 407 species and is widely distributed in Sri Lanka, India, China, 
Vietnam, Indonesia, Brazil and other Asian countries [3,4] is belongs to the family Celastraceae, formerly called as 
Hippocrataceae [5] It is popularly called as “Saptrangi” in Ayurvedic medicines [6]. Medicinally importance of this genus 
Salacia is seems to increasing as it was initially used in Ayurvedha for the treatment of Madhumeha which was the ancient 
name for diabetes [7]. 
 The number of people suffering from diabetes is increasing at an alarming rate worldwide [8] and the management 
of this disease is considered as a global problem and successful treatment is yet to be discovered. There are three types of 
diabetes a) Type I diabetes, b) Type II diabetes and c) Gestational diabetes. Of these three type II is most common and 
account in 90% cases. It is usually characterized by an abnormal increase in blood sugar especially after meal and is called 
as postprandial hyperglycemia [9]. 
 Amylases (α-1,4-glucan-4-glucanohydrolase, EC3.2.1.1) are a group of enzymes which catalyze the hydrolysis of 
the (α-1,4) glycosidic linkages in starch and various other oligosaccharides [10]. Hence, the inhibition of α-amylase delays 
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carbohydrate digestion and prolongs the overall carbohydrate digestion time, causing a reduction in the rate of glucose 
absorption, consequently blunting increased post – prandial plasma glucose levels [11]. 
 Alpha glucosidase is an important enzyme in the process of carbohydrate digestion. It catalyzes the hydrolysis of 
1, 4-glucosidic bonds within carbohydrates with release of α-glucose and promotes the increase of blood glucose level after 
meal. Alpha – glucosidase inhibitors antagonize the activity of α-glucosidase, thereby delaying intestinal carbohydrate 
absorption and slowing the sharp rise in blood sugar levels that diabetic patients typically experience after meals [12]. 
  Hence, the present study focussed to study the inhibitory activity of these two enzymes (i-e) α-amylase and α-
glucosidase in seven species of Salacia such as Salacia beddomei, Salacia chinensis, Salacia fruticosa, Salacia gambleana, 
Salacia macrosperma, Salacia malabarica and Salacia oblonga using Acarbose as a standard positive control  
 
2. Materials and Method 
2.1 Collection and Extraction of Plant Materials 
 Leaves of seven species of Salacia such as S.beddomei, S.chinensis, S.fruticosa, S.gambleana, S.macrosperma, 
S.malabarica and S.oblonga were collected from Wayanad district of Kerala. They are washed thoroughly and shade dried. 
They are coarsely powdered. 100g of powdered plant material was soaked in 300 ml of Methanol for 48hrs. The extract was 
filtered using Whattmann Filter paper and the filtrate was concentrated under reduced pressure in vacuum at 40°C for 
25min using a rotary evaporator. The percentage yield of extract was calculated using the formula, 
                                    WE – WC 
Percentage yield of extract =  ------------------ X 100 
                                      WE 
Where, WE – Weight of the extract 
             WC – Weight of the tube without extract 
 
2.2 In vitro Anti diabetic Activity 
a) Inhibition of alpha amylase enzyme 
A starch solution of 0.1% w/v was prepared by stirring 0.g of potato starch in 100 ml 0f 16 mM of Sodium acetate 
buffer.  The enzyme solution was prepared by mixing 27.5 mg of alpha amylase in 100ml of distilled water. The 
calorimetric reagent was prepared by mixing sodium potassium tartarate solution and 3,5 di nitro salicylic acid solution (96 
mM). The various concentrations of the plant extract (20 – 100 µg/ml) were added to 1 ml of starch solution and left for 10 
min. Further the reaction was initiated by the addition of the enzyme solution and allowed to react for 10 min under alkaline 
condition at 25°C. Finally the reaction was terminated by adding 1 ml of calorimetric reagent and then incubated in a 
boiling water bath for 5 min, cooled to room temperature. The reaction mixture was then diluted after adding 10 ml distilled 
water and absorbance was measured at 540 nm. Control represent 100% enzyme activity and were conducted in a similar 
way by replacing extract with DMSO. A similar experiment was conducted with the Standard drug Acarbose in triplicate. 
b) Inhibition of alpha glucosidase enzyme 
The inhibitory activity was determined by incubating a solution of Starch substrate (2% w/v maltose or sucrose) 1 
ml with 0.2M Tris buffer pH 8 and various concentrations of plant extracts for 5 min at 37°C. The reaction was initiated by 
adding 1ml of alpha glucosidase enzyme (1U/ml) to it followed by incubation for 40 min at 37°C. Then the reaction was 
terminated by the addition of 2 ml of 6N HCl. Then the intensity of colour was measured at 540 nm. Control experiment 
was done by replacing the extract with DMSO and also for a standard drug Acarbose in triplicate.  
2.3 Statistical analysis 
 The data was statistically analyzed by one-way ANNOVA using SPSS 17.0. The difference was considered 
significant when p˂0.005.Triplicate assays were performed for each set of test conditions. All the values were expressed as 
Mean±SD (Standard Deviation). IC50 Value is also calculated for all test conditions. 
 
3. Results  
3.1 Yield Percentage of Plant Samples 
 Methanolic extract of leaves of seven species of Salacia such as S.beddomei, S.chinensis, S.fruticosa, 
S.gambleana, S.macrosperma, S.malabarica and S.oblonga were used for this study. Yield Percentage of above seven 
species of Salacia was S.beddomei (47.71%), S.chinensis (41.47%), S.fruticosa (58.46%), S.gambleana (51.86), 
S.macrosperma (28.96%), S.malabarica (30.87%) and S.oblonga (52.75%).  
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 The order of yield percentage for seven species of Salacia is as follows, 
SF ˃SO˃ SG˃ SB˃ SC˃ SMAL˃ SMAC 
3.2 In vitro Anti diabetic Activity 
a) Inhibition of alpha amylase enzyme 
This study was aimed to evaluate the inhibitory activity of this enzyme for Methanolic extract of seven species of 
Salacia such as. S.beddomei,S.chinensis, S.fruticosa, S.gambleana, S.macrosperma, S.malabarica and S.oblonga. IC50 
Value was calculated for seven species and also for standard Acarbose. IC50 Value for seven species of Salacia was Salacia 
beddomei (122µg/ml), Salacia chinensis (112µg/ml), Salacia fruticosa (108µg/ml), Salacia gambleana (148µg/ml), Salacia 
macrosperma (125µg/ml), Salacia malabarica (121µg/ml), and Salacia oblonga (117µg/ml) (Table 1) (Figure 1 – 7). Alpha 
amylase inhibitory activity for seven species of Salacia can be arranged in ascending order was SF ˃SC ˃SO ˃SMAL ˃SB 
˃SMAC ˃SG.  
b) Inhibition of alpha glucosidase enzyme 
This study also explained the inhibitory activity of Alpha glucosidase enzyme for Methanolic extract of seven 
species of Salacia. The values are expressed as IC50 Value for seven species and also for standard Acarbose. IC50 Value for 
seven species of Salacia was S.beddomei (107µg/ml), S.chinensis (105µg/ml), S.fruticosa (80µg/ml), S.gambleana 
(110µg/ml), S.macrosperma (109µg/ml), S.malabarica (107µg/ml), and S.oblonga (108µg/ml) (Table 2) (Figure 8-14).The 
order wise arrangement of the Alpha glucosidase inhibitory activity was SF˃ SC˃ SB= SMAL ˃SO ˃SMAC˃ SG.  
 
Table 1: Inhibition of Alpha Amylase Enzyme 
S. 
No 
Concentration 
(µg) 
Acarbose 
(Mean±SD) 
Salacia 
beddomei 
(Mean±SD) 
Salacia 
chinensis 
(Mean±SD) 
Salacia 
fruticosa 
(Mean±SD) 
Salacia 
gambleana 
(Mean±SD) 
Salacia 
macrosperma 
(Mean±SD) 
Salacia 
malabarica 
(Mean±SD) 
Salacia 
oblonga 
(Mean±SD) 
1. 20 15.28±0.057 27.55±0.133 14.22±0.063 20.44±0.055 19.19±0.026 13.33±0.072 12.71±0.058 21.65±0.075 
2. 40 16.58±0.052 31.25±0.087 18.45±0.067 28.09±0.064 25.57±0.044 24.23±0.070 19.12±0.061 30.65±0.063 
3. 60 18.48±0.061 32.05±0.040 39.63±0.061 33.21±0.066 28.77±0.043 29.34±0.081 27.44±0.069 31.95±0.061 
4. 80 23.65±0.054 34.54±0.035 42.78±0.087 39.64±0.065 32.59±0.057 31.94±0.064 33.22±0.066 37.06±0.060 
5. 100 25.58±0.054 41.15±0.089 44.69±0.096 46.67±0.069 33.85±0.072 40.23±0.081 41.54±0.069 42.84±0.063 
 *IC50 Value 196µg/ml 122µg/ml 112µg/ml 108µg/ml 148µg/ml 125µg/ml 121µg/ml 117µg/ml 
 
Table 2: Inhibition of alpha glucosidase enzyme 
S. 
No 
Concentration 
(µg) 
Acarbose 
(Mean±SD) 
Salacia 
beddomei 
(Mean±SD) 
Salacia 
chinensis 
(Mean±SD) 
Salacia 
fruticosa 
(Mean±SD) 
Salacia 
gambleana 
(Mean±SD) 
Salacia 
macrosperma 
(Mean±SD) 
Salacia 
malabarica 
(Mean±SD) 
Salacia 
oblonga 
(Mean±SD) 
1. 20 15.28±0.057 32.92±0.040 26.54±0.032 24.96±0.086 29.46±0.065 20.08±0.060 22.07±0.052 26.97±0.059 
2. 40 16.58±0.052 37.33±0.0058 35.35±0.053 33.37±0.062 32.94±0.034 24.56±0.047 32.95±0.033 32.94±0.035 
3. 60 18.48±0.061 46.74±0.066 47.76±0.063 37.84±0.062 45.74±0.047 32.95±0.040 43.27±0.047 46.68±0.057 
4. 80 23.65±0.054 57.04±0.055 52.14±0.052 58.97±0.070 57.54±0.055 46.24±0.034 47.15±0.087 57.56±0.044 
5. 100 25.58±0.054 63.44±0.064 58.55±0.043 61.94±0.069 65.91±0.046 52.65±0.033 52.64±0.031 59.97±0.061 
 *IC50 Value 196µg/ml 107µg/ml 105µg/ml 80µg/ml 110µg/ml 109µg/ml 107µg/ml 108µg/ml 
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Fig 1. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia beddomei
S.Beddomei
Acarbose
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Fig 2. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia chinensis
S.chinensis
Acarbose
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Fig 3. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia fruticosa
S.fruticosa
Acarbose
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Fig 4. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia gambleana
S.gambleana
Acarbose
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Fig 5. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia malabarica
S.malabarica
Acarbose
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Fig 6. α-amylase inhibition activity of Acarbose and the 
methanolic extract of Salacia macrosperma
S.macrosperma
Acarbose
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Fig 7. α-amylase inhibition activity of Acarbose and the 
methanolic extracts of Salacia oblonga
S.oblonga
Acarbose
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Fig 8. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia beddomei
S.Beddomei
Acarbose
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Fig 9. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia chinensis
S.chinensis
Acarbose
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Fig 10. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia fruticosa
S.fruticosa
Acarbose
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Fig 11. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia gambleana
S.gambleana
Acarbose
0
10
20
30
40
50
60
20 40 60 80 100
%
 o
f 
in
h
ib
it
io
n
Concentration (µg/ml)
Fig 12. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia macrosperma
S.macrosperma
Acarbose
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Fig 13. α-glucosidase inhibition activity of Acarbose and the 
methanolic extract of Salacia malabarica
S.malabarica
Acarbose
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4. Discussion 
Diabetes includes the development of micro and macro vascular diabetic complications [13]. In humans, glucose 
tolerance impairs prior to maturity – onset of hyperglycemia [14] and is widely used as a clinical index to predict the 
potentiality of developing diabetes [15].  
Most of plants and their products are used as a valuable source of anti–diabetic drugs. In both Ayurvedic medicinal 
preparations and also Chinese medicinal preparations, includes various medicinal plants to treat diabetes [16, 17]. 
Alpha amylase is a salivary or pancreatic enzyme which plays an important role in earlier breakdown of starch to 
simpler sugars. The inhibitors of alpha amylase can delay the carbohydrate digestion and reduce the rate of glucose 
absorption. As a result there is a decrease in postprandial blood glucose level. Hence, they have been thought to improve 
glucose tolerance in diabetic patients [18, 19]. 
 In normal or impaired individuals, glucose tolerance can be found along with hyperinsulinemia. In such cases, 
alpha glucosidase inhibitors decrease hyperinsulinemia and improve insulin sensitivity [20]. It can be induce fasting 
hyperglycemia and be associated with coagulation activation and lipid metabolism abnormalities [21]. Alpha glucosidase 
inhibitors can delay the action of alpha glucosidases to break complex carbohydrates into simple sugars thereby lowering 
the absorption of glucose [22]. 
 Salacia is one of the valuable medicinal plants used in the treatment of diabetes. In the present study Methanolic 
leaf extracts of selected species of Salacia was used to evaluate both Alpha amylase and Alpha glucosidase inhibitory 
activities. They are considered as a rich source of active principles such as Salacinol and Kotalanol and used as alternative 
and less expensive therapies in diabetic management. 
 
5. Conclusion 
 The present study investigates the anti diabetic property of seven species of Salacia. It is basically attributed to the 
inhibitory activity of intestinal enzymes such as Alpha amylase and Alpha glucosidase. The inhibitory property of this 
extract may be attributed to the presence of phytochemicals such as saponins and flavonoids. Hence, this is a valuable 
genus which should be protected in all aspects. 
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